NASDAQ:PSNL
Personalis Inc. Stock News
$1.40
+0.0050 (+0.358%)
At Close: May 17, 2024
Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing
04:15pm, Tuesday, 28'th Nov 2023
FREMONT, Calif. & CHICAGO--(BUSINESS WIRE)--Personalis, Inc., a leader in advanced genomics for precision oncology (Nasdaq: PSNL), and Tempus Labs, Inc., a leader in artificial intelligence and precis
Personalis, Inc. (PSNL) Q3 2023 Earnings Call Transcript
11:04pm, Tuesday, 07'th Nov 2023
Personalis, Inc. (NASDAQ:PSNL ) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Caroline Corner - IR Chris Hall - CEO and President Aaron Tachibana - CFO and COO Rich
Personalis Reports Third Quarter 2023 Financial Results
04:01pm, Tuesday, 07'th Nov 2023
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the third quarter ended September 30, 2023
Personalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in Cancer
08:15am, Thursday, 26'th Oct 2023
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today the launch of the Early Access Program for NeXT Personal Dx, a
Personalis to Announce Third Quarter 2023 Financial Results
04:01pm, Tuesday, 24'th Oct 2023
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its third quarter 2023 financial results o
Analysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD Technology
04:25am, Saturday, 21'st Oct 2023
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in precision oncology, today announced the presentation of initial findings from its work with the groundbreaking TRACERx lu
Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
04:01pm, Tuesday, 29'th Aug 2023
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will present at the 21st Annual Morgan
Personalis to Announce First Quarter 2023 Financial Results
04:01pm, Wednesday, 19'th Apr 2023
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its first quarter 2023 financial results o
Personalis: Revisiting The Investment Thesis
01:11pm, Monday, 17'th Apr 2023
Today, we put diagnostic firm Personalis, Inc. back in the spotlight as the shares go for less than the company's net cash on the balance sheet. The company has brought in a new CEO and announced sign
Personalis (PSNL) Upgraded to Buy: Here's What You Should Know
01:33pm, Tuesday, 28'th Feb 2023
Personalis (PSNL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Personalis, Inc. (PSNL) Q4 2022 Earnings Call Transcript
11:36pm, Thursday, 23'rd Feb 2023
Personalis, Inc. (NASDAQ:PSNL ) Q4 2022 Results Conference Call February 23, 2023 5:00 PM ET Company Participants Caroline Corner - Investor Relations Aaron Tachibana - Interim Chief Financial Officer
A Short Guide to Making Money With Penny Stocks in 2023
11:00am, Saturday, 04'th Feb 2023
Use these tips for making money with penny stocks The post A Short Guide to Making Money With Penny Stocks in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Personalis: Looking For A Potential Turnaround In 2023
09:10pm, Tuesday, 17'th Jan 2023
Personalis is a small-cap cancer genomics company with a next-gen cancer diagnostics platform whose stock has lost over 80% of its value over the past twelve months. Personalis is reporting substantia
Personalis, Inc. (PSNL) Q3 2022 Earnings Call Transcript
10:49pm, Wednesday, 02'nd Nov 2022
Personalis, Inc. (NASDAQ:PSNL ) Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants Caroline Corner - Investor Relations John West - President and Chief Executive Officer
Personalis (PSNL) Reports Q3 Loss, Misses Revenue Estimates
09:15pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
Personalis (PSNL) delivered earnings and revenue surprises of 7.94% and 5.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?